All materials.

lot VRL-BPC-2601

A pentadecapeptide fragment derived from a protective protein found in gastric juice. Widely studied in preclinical models of tissue repair, gut mucosal integrity, and angiogenic signaling.

lot VRL-RST-2601

A paired research stack combining BPC-157 and TB-500 in one vial format for investigators studying overlapping tissue-repair, angiogenic, and cell-migration pathways.

lot VRL-TB5-2603

A synthetic peptide corresponding to an active region of Thymosin β4, an actin-binding protein involved in cell migration and wound repair in preclinical models.

lot VRL-GHK-2601

A naturally occurring copper-binding tripeptide studied extensively in models of fibroblast activity, collagen synthesis, and skin matrix remodeling.

lot VRL-CJC-2602

A tetrasubstituted analog of GHRH(1-29) engineered for metabolic stability. Widely used in preclinical research on pulsatile growth hormone release.

lot VRL-IPA-2601

A pentapeptide growth hormone secretagogue receptor agonist developed as a research tool for selective GH release without significant cortisol or prolactin elevation in published preclinical models.

lot VRL-TES-2601

A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. A GHRH analog studied in GH/IGF-1 axis and adipose-tissue pathway literature.

lot VRL-SEM-2604

A long-acting analog of human glucagon-like peptide-1 with extensive published literature across glycemic, weight, and cardiovascular research endpoints.

lot VRL-TIR-2603

A synthetic 39-amino-acid peptide engineered as a unimolecular dual agonist at the GIP and GLP-1 receptors. Extensive recent literature in glycemic and metabolic pathway research.

lot VRL-RET-2604

A next-generation synthetic peptide engineered as a unimolecular triple agonist at the GIP, GLP-1, and glucagon receptors. Actively studied in Phase 2/3 trials and an object of intense research interest.

lot VRL-MOT-2603

A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA region, studied as a metabolic signaling molecule and modulator of AMPK-dependent pathways.

lot VRL-EPI-2602

A short tetrapeptide first characterized in Russian longevity research as a putative bioregulator of pineal function and telomerase activity in preclinical models.

lot VRL-PT1-2601

A cyclic heptapeptide analog of α-MSH acting at central melanocortin receptors. Studied as a melanocortin receptor research tool across central signaling literature.

lot VRL-NAD-2603

The oxidized form of nicotinamide adenine dinucleotide, supplied as a research-grade reference standard for redox biology, mitochondrial function, and sirtuin-pathway studies.

lot VRL-BBG70-2604

A 70 mg multi-peptide research stack combining BPC-157 10 mg, GHK-Cu 50 mg, and TB-500 10 mg in one vial. Positioned for pathway-combination studies spanning connective tissue, fibroblast signaling, and tissue remodeling research.

lot VRL-KLW-2601

An 80 mg multi-peptide research stack combining BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg, and KPV 10 mg in one vial, positioned for investigators studying overlapping matrix biology, fibroblast, barrier, and inflammatory signaling pathways.